Psyence Biomedical Ltd.
PBM
$3.48
-$0.08-2.25%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.04M | 4.36M | 3.67M | 3.41M | 3.37M |
| Depreciation & Amortization | 5.20K | 5.10K | 5.00K | 4.70K | 4.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.53M | 5.49M | 4.45M | 4.10M | 3.85M |
| Operating Income | -6.53M | -5.49M | -4.45M | -4.10M | -3.85M |
| Income Before Tax | -6.69M | -5.20M | -3.70M | -2.80M | -327.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.69 | -5.20 | -3.70 | -2.80 | -0.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.69M | -5.20M | -3.70M | -2.80M | -327.00K |
| EBIT | -6.53M | -5.49M | -4.45M | -4.10M | -3.85M |
| EBITDA | -6.53M | -5.48M | -4.44M | -4.09M | -3.85M |
| EPS Basic | -14.34 | -28.75 | -43.16 | -39.98 | -34.11 |
| Normalized Basic EPS | -11.70 | -18.79 | -25.88 | -21.94 | -17.48 |
| EPS Diluted | -14.35 | -28.76 | -43.17 | -39.98 | -34.11 |
| Normalized Diluted EPS | -11.70 | -18.79 | -25.88 | -21.94 | -17.48 |
| Average Basic Shares Outstanding | 2.28M | 1.40M | 520.70K | 283.70K | 114.20K |
| Average Diluted Shares Outstanding | 2.28M | 1.40M | 520.70K | 283.70K | 114.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |